Tag: Immutep
Immutep: Receives FDA Fast Track designation for NSCLC treatment
Immutep Receives FDA Fast Track designation for NSCLC treatmentImmutep (IMM) receives US FDA Fast Track designation for its...
Immutep: Shares positive data from phase 2b AIPAC trial
Immutep Shares positive data from phase 2b AIPAC trialImmutep (IMM) sees a significant increase in innate and adaptive immune...
Immutep: Completes Phase II recruitment
Immutep Completes Phase II recruitmentImmutep (IMM) completes recruitment for its phase II study for non-small cell lung cancer
...
Immutep: Receives $3.4 million R&D tax incentive
Immutep Receives $3.4 million R&D tax incentiveImmutep (IMM) is granted a $3.4 million research and development tax incentive...
Immutep: Advances phase two efti study for COVID-19 patients
Immutep's (IMM) phase two Eftilagimod Alpha Treatment COVID (EAT COVID) study will soon advance to enrolment ahead of...
Immutep: Invests nearly $30M for ongoing clinical trials
Biotech company Immutep (IMM) has tapped institutional investors for a neat $29.6 million to fund its cancer and...
Immutep: Reveals encouraging interim results from phase two TACTI-002 study
Immutep (IMM) has released further interim data from its Phase II TACTI-002 Study in patients with lung, head,...
Immutep: Partners with LabCorp
Immutep (IMM) has entered a license and collaboration agreement with Laboratory Corporation of American Holdings (LabCorp)
The companies...
Immutep: Sees improved results from two cancer trial
Cancer treatment company Immutep (IMM) has seen improving results from its cancer trials, INSIGHT-004 and TACTI-002
For the...
Immutep: Reports data from two separate cancer trials
Immutep: Reports data from two separate cancer trialsCancer treatment company Immutep (IMM) has released results from two separate...
Immutep: Receives A$3.6M from French Govt.
Immutep: Receives A$3.6M from French Govt.Biotech company Immutep (IMM) has also received €2,173,454 (roughly A$3.6 million) from the...
Immutep: Granted Japanese patent for efti
Immutep: Granted Japanese patent for eftiBiotech company Immutep has been granted a patent from the Japanese Patent Office...